GNH USA

Europe — EMA

Imukin

GNH USA supplies Imukin (Recombinant Human Interferon Gamma-1b), an interferon for chronic granulomatous disease and severe malignant osteopetrosis.

Recombinant Human Interferon Gamma 1b

Request sourcing

1
Pack/s

What is Recombinant Human Interferon Gamma 1b?

Recombinant human interferon gamma-1b, the active ingredient in Imukin, is an interferon presented as a sterile solution for subcutaneous use. It is used to treat chronic granulomatous disease and severe malignant osteopetrosis in appropriate patients.

GNH USA supplies Imukin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Recombinant Human Interferon Gamma 1b used for?

Imukin is an interferon that modulates immune function in specific inherited and bone disorders.

Chronic granulomatous disease (CGD): enhances macrophage killing to reduce severe infections. Severe malignant osteopetrosis (SMO): promotes bone remodeling and supports hematopoietic recovery. Adjunct therapy in selected hematologic disorders: modulates immune response to improve treatment outcomes.

What are the side effects of Recombinant Human Interferon Gamma 1b?

Common Side Effects: - Fever - Injection site reactions (redness, swelling) - Fatigue - Headache

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis - Autoimmune hepatitis - Hematologic abnormalities such as neutropenia or thrombocytopenia

What precautions apply to Recombinant Human Interferon Gamma 1b?

Before initiating therapy, consider the following precautions: - Monitor blood counts: watch for neutropenia or thrombocytopenia. - Assess liver function: interferon gamma may exacerbate hepatic inflammation. - Evaluate for pre‑existing autoimmune disease: risk of flare. - Use with caution in patients with severe cardiac disease. - Avoid in individuals with known hypersensitivity to interferon products. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Recombinant Human Interferon Gamma 1b interact with?

Imukin may interact with several medicines; review the following.

Major Interactions (Avoid): - Live attenuated vaccines: interferon gamma can diminish vaccine efficacy and increase risk. - High‑dose systemic corticosteroids: may blunt immunomodulatory effects. - Concurrent use of other interferons: increased risk of overlapping toxicities.

Moderate Interactions (Monitor Closely): - Azathioprine or mycophenolate: may enhance immunosuppression. - Antiretroviral agents (e.g., protease inhibitors): potential alteration of drug metabolism. - Anticoagulants (e.g., warfarin): monitor coagulation parameters for variability.

Frequently asked questions

What conditions is Imukin used to treat?+
Imukin, containing recombinant human interferon gamma-1b, is approved for the treatment of chronic granulomatous disease, a primary immunodeficiency, and severe malignant osteopetrosis, a rare bone disorder. In both conditions, the drug helps restore immune function or supports bone remodeling as part of a comprehensive therapeutic plan.
How does recombinant human interferon gamma-1b work in the body?+
The molecule binds to interferon gamma receptors on immune cells, activating the JAK‑STAT signaling cascade. This activation enhances macrophage microbicidal activity, increases antigen presentation, and drives a Th1‑type immune response, which together improve the body’s ability to combat intracellular pathogens and influence bone turnover.
What is the usual dose of Imukin?+
The specific dose and dosing schedule of Imukin are determined by the prescribing clinician based on the patient’s age, weight, disease severity, and response to therapy. Healthcare providers tailor the regimen to achieve optimal clinical benefit while monitoring safety.
Is Imukin safe to use during pregnancy or breastfeeding?+
Safety data for recombinant human interferon gamma-1b in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Imukin from GNH USA?+
To request Imukin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain logistics if needed—and necessary import documentation.
How does Imukin compare with other interferon therapies?+
Imukin (interferon gamma‑1b) differs from interferon‑alpha or beta products by specifically promoting Th1 immune responses and macrophage activation, making it suitable for conditions like CGD and SMO. Other interferons target viral replication or multiple sclerosis pathways, so the choice depends on the disease mechanism and therapeutic goals.
What are the recommended storage conditions for Imukin?+
Imukin should be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking. If the product must be transported, maintain the cold chain to preserve stability and potency.
How is Imukin administered to patients?+
Imukin is given by subcutaneous injection, typically into the abdomen or thigh. The injection site should be rotated to minimize local reactions, and aseptic technique must be followed. Administration is performed by a healthcare professional or a trained caregiver under medical supervision.
What are the most serious risks associated with Imukin?+
Serious risks include severe allergic reactions such as anaphylaxis, autoimmune hepatitis, and significant hematologic abnormalities like neutropenia or thrombocytopenia. Patients should be monitored regularly for signs of these events, and treatment should be discontinued if any serious reaction occurs.
Who should not receive Imukin?+
Imukin is contraindicated in individuals with known hypersensitivity to interferon gamma‑1b or any excipients in the formulation. It should also be avoided in patients receiving live attenuated vaccines or those with uncontrolled autoimmune disease unless the benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Recombinant Human Interferon Gamma 1b
Route
Subcutaneous Use
Manufacturer
Clinigen Healthcare B.V.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU